# FDA 483 - Samsung Biologics Co., Ltd. - June 09, 2022

Source: https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/caf2bc64-dcd8-4d80-a40d-ca04258e6266

> FDA 483 for Samsung Biologics Co., Ltd. on June 09, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Samsung Biologics Co., Ltd.
- Inspection Date: 2022-06-09
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-05-27](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/b3a6afca-acc1-42d3-9eaa-a9c039d1bb0a)
- [483 - 2019-11-01](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/1c9c660e-55a8-402f-94c5-5e593800a465)
- [483 - 2022-06-09](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/134cfe7e-fea2-4b96-9e87-ef42c2597d55)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/c538365f-d341-4355-b8f0-102fee55862d)
- [483 - 2021-08-24](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/f660cf8a-50b8-4766-b37d-4605324fd16b)

## Related Officers

- [Madushini N. Dharmasena](https://www.globalkeysolutions.net/people/madushini-n-dharmasena/c6dbff15-4c5f-475e-8ec1-581d8e65f76c)

Company: https://www.globalkeysolutions.net/companies/samsung-biologics-co-ltd/817b7bc4-2de1-47f4-b552-178303c8da01

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd